docid,section,sentenceid_gold,subject_text_gold,subject_type_gold,object_text_gold,object_type_gold,relation_gold,trigger_text_gold,sub_norm,obj_norm,sentenceid_model,subject_text_model,subject_type_model,object_text_model,object_type_model,relation_model,trigger_text_model,_merge
15623373,abstract,10,tissues,Tissue,cancer,Neoplastic Process,LOCATION_OF,,tissues,cancer,10,tissues,Tissue,cancer,Neoplastic Process,PART_OF,,both
15623373,abstract,10,tissues,Tissue,MMP-2,"Amino Acid, Peptide, or Protein",PRODUCES,expression,tissues,mmp-2,10,tissues,Tissue,MMP-2,Gene or Genome,LOCATION_OF,,both
15623373,abstract,10,tissues,Tissue,VEGF,"Amino Acid, Peptide, or Protein",PRODUCES,expression,tissues,vegf,10,tissues,Tissue,VEGF,"Amino Acid, Peptide, or Protein",LOCATION_OF,,both
15808413,abstract,5,nitrite,Chemical Viewed Structurally,nitrate,Inorganic Chemical,CONVERTS_TO,oxidized,nitrite,nitrate,5,nitrite,Chemical Viewed Structurally,nitrate,Inorganic Chemical,INTERACTS_WITH,,both
15927218,abstract,1,Neurocysticercosis,Disease or Syndrome,neurological disease,Disease or Syndrome,CAUSES,causes,neurocysticercosis,neurological disease,1,Neurocysticercosis,Disease or Syndrome,neurological       disease,Disease or Syndrome,ISA,,both
15993962,abstract,1,implantation,Therapeutic or Preventive Procedure,restenosis,Acquired Abnormality,TREATS,for,implantation,restenosis,1,implantation,Therapeutic or Preventive Procedure,restenosis,Acquired Abnormality,PRECEDES,,both
15996060,title,1,Sex hormone,Hormone,patients,Human,PART_OF,in,sex hormone,patients,1,Sex hormone,Hormone,patients,Patient or Disabled Group,TREATS,,both
15996060,abstract,2,estrogens,Hormone,women,Human,PART_OF,in,estrogens,women,2,estrogens,Pharmacologic Substance,women,Population Group,TREATS,,both
15996060,abstract,10,sex hormones,Human,patients,Hormone,LOCATION_OF,in,sex hormones,patients,10,sex hormones,Hormone,patients,Patient or Disabled Group,TREATS,,both
16080004,abstract,8,safrole,Hazardous or Poisonous Substance,cell proliferation,Cell Function,AFFECTS,alter,safrole,cell proliferation,8,safrole,Organic Chemical,cell       proliferation,Cell Function,AUGMENTS,,both
16080004,abstract,8,safrole,Organic Chemical,cell proliferation,Cell Function,AUGMENTS,increased,safrole,cell proliferation,8,safrole,Hazardous or Poisonous Substance,cell       proliferation,Cell Function,AFFECTS,,both
16141404,abstract,6,SFLLRN,"Amino Acid, Peptide, or Protein",EPC,Cell,AUGMENTS,stimulation,sfllrn,epc,6,SFLLRN,"Amino Acid, Peptide, or Protein",EPC,opco,STIMULATES,,both
16204062,abstract,4,gene amplification,Genetic Function,PKCiota,"Amino Acid, Peptide, or Protein",STIMULATES,drives,gene amplification,pkciota,4,gene       amplification,Genetic Function,PKCiota,Gene or Genome,PROCESS_OF,,both
16230392,abstract,2,EP2,Gene or Genome,tumorigenesis,Neoplastic Process,ASSOCIATED_WITH,role,ep2,tumorigenesis,2,EP2,Gene or Genome,tumorigenesis,Neoplastic Process,AFFECTS,,both
16243512,abstract,4,beta-amyloid,"Amino Acid, Peptide, or Protein",Alzheimer's disease,Disease or Syndrome,CAUSES,implicated,amyloid,alzheimers disease,4,amyloid,"Amino Acid, Peptide, or Protein",Alzheimer's       disease,Disease or Syndrome,AFFECTS,,both
16372914,abstract,2,oncofetal antigen,"Amino Acid, Peptide, or Protein",malignancies,Neoplastic Process,PART_OF,expressed,oncofetal antigen,malignancies,2,oncofetal antigen,"Amino Acid, Peptide, or Protein",malignancies,Neoplastic Process,ASSOCIATED_WITH,,both
16394795,abstract,12,proctitis,Disease or Syndrome,constipation,Sign or Symptom,MANIFESTATION_OF,characterized,proctitis,constipation,12,proctitis,Disease or Syndrome,constipation,Sign or Symptom,COEXISTS_WITH,,both
16411522,abstract,8,operation,Therapeutic or Preventive Procedure,patients,Patient or Disabled Group,ADMINISTERED_TO,underwent,operation,patients,8,operation,Therapeutic or Preventive Procedure,patients,Patient or Disabled Group,TREATS,,both
16412044,title,1,synthetic peptide,"Amino Acid, Peptide, or Protein",rats,Mammal,ADMINISTERED_TO,immunization,synthetic peptide,rats,1,synthetic peptide,"Amino Acid, Peptide, or Protein",rats,Mammal,PART_OF,,both
16418362,abstract,6,deep-brain stimulation,Therapeutic or Preventive Procedure,patients,Human,ADMINISTERED_TO,undergoing,deep-brain stimulation,patients,6,deep-brain stimulation,Therapeutic or Preventive Procedure,patients,Patient or Disabled Group,TREATS,,both
16436670,abstract,5,IFN-alpha,"Amino Acid, Peptide, or Protein",GTPase,"Amino Acid, Peptide, or Protein",INTERACTS_WITH,regulation,ifn,gtpase,5,IFN-alpha,"Amino Acid, Peptide, or Protein",GTPase,Gene or Genome,STIMULATES,,both
16462770,abstract,11,cell death,Cell Function,NSCLC,Neoplastic Process,COEXISTS_WITH,in,cell death,nsclc,11,cell death,Cell Function,NSCLC,Neoplastic Process,PROCESS_OF,,both
16503761,abstract,7,TZDs,Pharmacologic Substance,ovulation,Organ or Tissue Function,AUGMENTS,improved,tzds,ovulation,7,TZDs,Organic Chemical,ovulation,Organ or Tissue Function,AFFECTS,,both
16513142,abstract,3,repetitive sequences,Nucleotide Sequence,minisatellites,"Nucleic Acid, Nucleoside, or Nucleotide",PART_OF,in,repetitive sequences,minisatellites,3,repetitive sequences,Nucleotide Sequence,minisatellites,Biologically Active Substance,COEXISTS_WITH,,both
16540467,abstract,6,RA,Organic Chemical,transcription,Genetic Function,AFFECTS,dependent,ra,transcription,6,RA,Organic Chemical,transcription,Genetic Function,AUGMENTS,,both
16641628,abstract,6,Treacher Collins syndrome,Congenital Abnormality,patients,Human,PROCESS_OF,with,treacher collins syndrome,patients,6,Treacher Collins syndrome,Congenital Abnormality,patients,Human,PART_OF,,both
16879324,abstract,1,melatonin,Hormone,blood-brain barrier,"Body Part, Organ, or Organ Component",AFFECTS,decrease,melatonin,blood-brain barrier,1,melatonin,Hormone,blood-brain barrier,Organ or Tissue Function,AUGMENTS,,both
16879324,abstract,1,melatonin,Hormone,blood-brain barrier,Organ or Tissue Function,AFFECTS,decreases the late (24 hr) increase in,melatonin,blood-brain barrier,1,melatonin,Hormone,blood-brain barrier,Organ or Tissue Function,AUGMENTS,,both
16902165,abstract,3,EPC,Cell,patients,Human,PART_OF,in,epc,patients,3,EPC,Pharmacologic Substance,patients,Patient or Disabled Group,TREATS,,both
17135279,abstract,9,DYRK1A,Gene or Genome,tau,"Amino Acid, Peptide, or Protein",INTERACTS_WITH,bridging,dyrk1a,tau,9,DYRK1A,Gene or Genome,tau,"Amino Acid, Peptide, or Protein",PRODUCES,,both
17135279,abstract,9,DYRK1A,Gene or Genome,beta-amyloid,"Amino Acid, Peptide, or Protein",INTERACTS_WITH,bridging,dyrk1a,amyloid,9,DYRK1A,Gene or Genome,amyloid,"Amino Acid, Peptide, or Protein",PRODUCES,,both
